Inhibiting Tyrosine Kinase 2 Improves Kidney Issues in Antiphospholipid Syndrome
Author Information
Author(s): Kuo-Tung Tang, Yu-Sin Chen, Tzu-Ting Chen, Ya-Hsuan Chao, Shu-Ping Kung, Der-Yuan Chen, Chi-Chien Lin
Primary Institution: National Chung Hsing University
Hypothesis
Type I interferon is crucial in the generation of APS nephropathy.
Conclusion
The study shows that inhibiting Tyk2 can improve kidney function in a mouse model of APS nephropathy.
Supporting Evidence
- The Tyk2 inhibitor reversed the elevation of blood urea nitrogen and microalbuminuria in the murine model of APS nephropathy.
- Pathological vascular changes in the kidney were reversed as judged by electron microscopy.
- An increased expression of IFN signature in the kidneys of APS mice was found, which was reversed by Tyk2 inhibition.
Takeaway
This study found that a new medicine can help fix kidney problems in mice with a disease that causes blood clots.
Methodology
The study used a mouse model of APS nephropathy and administered a Tyk2 inhibitor to evaluate its effects on kidney function.
Limitations
The study was conducted in mice, and further human studies are needed.
Participant Demographics
Six-week-old female BALB/c mice were used in the study.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website